Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Nov 22, 2019

In this interview, Spencer King and David Fitchett discuss the relationship between hypoglycemia outcomes and empagliflozin treatment in the EMPA-REG OUTOME trial (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients).